Skip to main content
Integrated Proteins Ltd. logo

Integrated Proteins Ltd. — Investor Relations & Filings

Ticker · 519606 ISIN · INE177M01013 BSE.NS Manufacturing
Filings indexed 305 across all filing types
Latest filing 2025-02-14 Regulatory Filings
Country IN India
Listing BSE.NS 519606

About Integrated Proteins Ltd.

https://www.integratedproteins.com/

Integrated Proteins Ltd. specializes in the processing and manufacturing of protein-rich products and edible oils. The company operates a solvent extraction plant focused on the production of de-oiled cakes and refined oils, primarily derived from soybeans and other oilseeds. Its core activities include the extraction of high-quality vegetable proteins used extensively in the animal feed industry, particularly for poultry and aquaculture. The company maintains integrated facilities to ensure quality control throughout the production cycle, from raw material sourcing to the final extraction process. By leveraging advanced solvent extraction technology, Integrated Proteins Ltd. produces nutrient-dense soy meal and refined vegetable oils that serve both domestic and international food and feed sectors. The organization emphasizes technical efficiency and product consistency to meet the rigorous standards of the global protein market.

Recent filings

Filing Released Lang Actions
Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), and ....
Regulatory Filings
2025-02-14 English
INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve the unaudited financial ....
Regulatory Filings Classification · 95% confidence The document is a short notice from Integrated Proteins Limited informing the stock exchange (BSE Limited) about an upcoming board meeting scheduled for 14th February 2025. The purpose of the meeting includes approval of unaudited financial results for the quarter ended December 2024 along with the Limited Review Report. It also mentions the trading window closure and reopening dates. The document does not contain the financial results or the Limited Review Report itself, but only announces the meeting and the intention to approve those results. The document length is only 1425 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about upcoming board meetings and financial results approval are best classified as Regulatory Filings (RNS), since it is a general regulatory announcement and does not contain substantive financial data or the report itself.
2025-02-11 English
Outcome of Meeting of the board of the director of the company held on February 04, 2025
Regulatory Filings
2025-02-04 English
Outcome of Meeting of Board of Directors of the company held on February 03, 2025
Regulatory Filings
2025-02-03 English
Outcome of the Meeting of Board of Directors of the Company held today i.e. February 01, 2025
Regulatory Filings
2025-02-01 English
Allotment of 44,00,000 (Forty-Four Lakh) out of 2,00,00,000 (Two Crore) Convertible Equity Warrants on Preferential Basis to the allottees.
Regulatory Filings
2025-01-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.